Effect of different levels of acute hypoxia on subsequent oral glucose tolerance in males with overweight: A balanced cross‐over pilot feasibility study
Physiological Reports · 2023
DOI: 10.14814/phy2.15623 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2023. Verfasst von Jo Corbett und 9 weiteren Autor:innen. Beteiligte Einrichtung: Extreme Environments Laboratory, School of Sport, Health and Exercise Science, University of Portsmouth, Portsmouth, UK. Hauptthemen laut MEDLINE: Insulin Resistance, Altitude Sickness. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Previous research has shown that ≤60 min hypoxic exposure improves subsequent glycaemic control, but the optimal level of hypoxia is unknown and data are lacking from individuals with overweight. We undertook a cross‐over pilot feasibility study investigating the effect of 60‐min prior resting exposure to different inspired oxygen fractions (CON F I O 2 = 0.209; HIGH F I O 2 = 0.155; VHIGH F I O 2 = 0.125) on glycaemic control, insulin sensitivity, and oxidative stress during a subsequent oral glucose tolerance test (OGTT) in males with overweight (mean (SD) BMI = 27.6 (1.3) kg/m 2 ; n = 12). Feasibility was defined by exceeding predefined withdrawal criteria for peripheral blood oxygen saturation (SpO 2 ), partial pressure of end‐tidal oxygen or carbon dioxide and acute mountain sickness (AMS), and dyspnoea symptomology. Hypoxia reduced SpO 2 in a stepwise manner (CON = 97(1)%; HIGH = 91(1)%; VHIGH = 81(3)%, p < 0.001), but did not affect peak plasma glucose concentration (CON = 7.5(1.8) mmol∙L −1 ; HIGH = 7.7(1.1) mmol∙L −1 ; VHIGH = 7.7(1.1) mmol∙L −1 ; p = 0.777; η 2 = 0.013), plasma glucose area under the curve, insulin sensitivity, or metabolic clearance rate of glucose ( p > 0.05). We observed no between‐conditions differences in oxidative stress ( p > 0.05), but dyspnoea and AMS symptoms increased in VHIGH ( p < 0.05), with one participant meeting the withdrawal criteria. Acute HIGH or VHIGH exposure prior to an OGTT does not influence glucose homeostasis in males with overweight, but VHIGH is associated with adverse symptomology and reduced feasibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Extreme Environments Laboratory, School of Sport, Health and Exercise Science, University of Portsmouth, Portsmouth, UK.
- Clinical, Health and Rehabilitation Team, School of Sport, Health and Exercise Science, University of Portsmouth, Portsmouth, UK.
- National Horizons Centre, Teesside University, Middlesbrough, UK.
- School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
- Diabetes and Endocrinology Department, Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
- Centre for Sport Exercise and Health, Dept Medicine, University College London, London, UK.
ORCID-Profile: Jo Corbett, Michael P W Grocott
Zitieren
APA
Corbett, J., Tipton, M. J., Perissiou, M., James, T., Young, J. S., Newman, A., Cummings, M., Montgomery, H., Grocott, M. P. W., & Shepherd, A. I. (2023). Effect of different levels of acute hypoxia on subsequent oral glucose tolerance in males with overweight: A balanced cross‐over pilot feasibility study. Physiological Reports. https://doi.org/10.14814/phy2.15623
Vancouver
Corbett J, Tipton MJ, Perissiou M, James T, Young JS, Newman A, et al. Effect of different levels of acute hypoxia on subsequent oral glucose tolerance in males with overweight: A balanced cross‐over pilot feasibility study. Physiological Reports. 2023. doi:10.14814/phy2.15623
BibTeX
@article{Corbett2023,
author = {Corbett, Jo and Tipton, Michael J and Perissiou, Maria and James, Thomas and Young, John S and Newman, Alexander and Cummings, Michael and Montgomery, Hugh and Grocott, Michael P W and Shepherd, Anthony I},
title = {Effect of different levels of acute hypoxia on subsequent oral glucose tolerance in males with overweight: A balanced cross‐over pilot feasibility study},
journal = {Physiological Reports},
year = {2023},
doi = {10.14814/phy2.15623}
}
EUVIMED